This procurement opportunity is part of the project "Improving the Quality and Accessibility of Oncology Diagnostics and Treatment at the University Clinical Center," funded by the National Recovery and Resilience Plan. The project aims to enhance the efficiency, accessibility, and quality of the he
Tender closed on 15 Jul 2025. Awaiting award.
No single supplier dominates the field.
In healthcare medical, UNIVERSITY CLINICAL CENTER has awarded 133 contracts to 59 suppliers.
+53 more suppliers
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the supply of laboratory reagents and materials for IHC (Immunohistochemistry) and ISH (In Situ Hybridization) staining, along with the leasing of necessary equipment for the Clinical Pathology Department at the University Clinical Center. The required specifications, estimate
This procurement opportunity is part of the project aimed at enhancing the quality and accessibility of oncological diagnostics and treatment at the University Clinical Center (UCK). The project is funded under the National Recovery and Resilience Plan, specifically Component D, which focuses on imp
This contract involves the supply of lung perfusion products and buffered extracellular fluid for lung perfusion. Suppliers are required to provide the products as specified in Annex 3a and Annex 3b of the procurement documentation. The estimated quantities and specific requirements for these produc
This contract involves the delivery of pharmaceutical products as specified in the attached document (Annex 3 to the SWZ). The estimated quantity and specific requirements for the products are detailed in that annex. Suppliers are invited to provide these medical products to the University Clinical
Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.
Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.
UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.
Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.